Prestige Consumer Healthcare Inc. (PBH)
Stock Price Chart
Key Info
| Market Cap | 1.82B |
| Revenue (ttm) | 960.25M |
| Net Income (ttm) | 152.06M |
| Shares Out | 50.19M |
| EPS (ttm) | 2.99 |
| PE Ratio | 12.14 |
| Forward PE | 12.05 |
| Dividend | n/a |
| Dividend Yield | n/a |
Stock Quote
| Trading Day | Oct 16, 2020 |
| Last Price | $36.29 |
| Previous Close | $36.15 |
| Change ($) | 0.14 |
| Change (%) | 0.39% |
| Day's Open | 36.34 |
| Day's Range | 36.14 - 36.93 |
| Day's Volume | 230,078 |
| 52-Week Range | 27.40 - 46.12 |
More Stats
| Market Cap | 1.82B |
| Enterprise Value | 3.42B |
| Earnings Date (est) | Nov 5, 2020 |
| Ex-Dividend Date | n/a |
| Shares Outstanding | 50.19M |
| Float | 49.74M |
| EPS (basic) | 3.03 |
| EPS (diluted) | 2.99 |
| FCF / Share | 4.46 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Earnings Yield | 8.24% |
| FCF Yield | 12.32% |
| Payout Ratio | n/a |
| Shares Short | 4.22M |
| Short Ratio | 10.30 |
| Short % of Float | 8.48% |
| Beta | 0.75 |
| PE Ratio | 12.14 |
| Forward PE | 12.05 |
| P/FCF Ratio | 8.12 |
| PS Ratio | 1.90 |
| PB Ratio | 1.48 |
| Revenue | 960.25M |
| Operating Income | 299.79M |
| Net Income | 152.06M |
| Free Cash Flow | 224.34M |
| Net Cash | -1.60B |
| Net Cash / Share | -31.83 |
| Gross Margin | 58.91% |
| Operating Margin | 31.22% |
| Profit Margin | 15.80% |
| FCF Margin | 23.36% |
| ROA | 5.59% |
| ROE | 13.06% |
| ROIC | 15.20% |
Analyst Summary
Analyst Consensus: Overweight
Financial Performance
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 963 | 976 | 1,041 | 882 | 806 | 715 | 597 | 620 | 441 | 337 |
| Revenue Growth | -1.31% | -6.28% | 18.04% | 9.4% | 12.82% | 19.63% | -3.67% | 40.59% | 31.08% | - |
| Gross Profit | 552 | 556 | 577 | 500 | 467 | 406 | 336 | 344 | 227 | 171 |
| Operating Income | 291 | 66.22 | 215 | 257 | 260 | 208 | 189 | 192 | 103 | 76.15 |
| Net Income | 142 | -35.80 | 340 | 69.40 | 99.91 | 78.26 | 72.62 | 65.51 | 37.21 | 29.22 |
| Shares Outstanding | 50.72 | 52.07 | 53.10 | 52.98 | 52.75 | 52.17 | 51.64 | 50.63 | 50.27 | 50.08 |
| Earnings Per Share | 2.78 | -0.69 | 6.34 | 1.30 | 1.88 | 1.49 | 1.39 | 1.27 | 0.73 | 0.58 |
| EPS Growth | - | - | 387.69% | -30.85% | 26.17% | 7.19% | 9.45% | 73.97% | 25.86% | - |
| Operating Cash Flow | 217 | 189 | 210 | 149 | 176 | 156 | 112 | 138 | 67.45 | 86.67 |
| Capital Expenditures | -14.56 | -10.48 | -12.53 | -2.89 | -3.22 | 3.90 | -2.76 | -10.25 | -0.61 | -0.64 |
| Free Cash Flow | 203 | 179 | 198 | 146 | 173 | 160 | 109 | 127 | 66.85 | 86.03 |
| Cash & Equivalents | 94.76 | 27.53 | 32.55 | 41.86 | 27.23 | 21.32 | 28.33 | 15.67 | 19.02 | 13.33 |
| Total Debt | 1,767 | 1,799 | 1,993 | 2,194 | 1,625 | 1,561 | 934 | 971 | 1,124 | 487 |
| Net Cash / Debt | -1,672 | -1,771 | -1,960 | -2,152 | -1,598 | -1,540 | -906 | -955 | -1,105 | -474 |
| Assets | 3,514 | 3,441 | 3,761 | 3,911 | 2,949 | 2,642 | 1,796 | 1,740 | 1,758 | 1,057 |
| Liabilities | 2,343 | 2,345 | 2,582 | 3,089 | 2,204 | 2,014 | 1,232 | 1,262 | 1,356 | 695 |
| Book Value | 1,171 | 1,096 | 1,179 | 823 | 744 | 628 | 563 | 478 | 403 | 362 |
Company Profile
Company Details
| Full Name | Prestige Consumer Healthcare Inc. |
| Country | United States |
| Employees | 520 |
| CEO | Ronald M. Lombardi |
Stock Information
| Ticker Symbol | PBH |
| Stock Exchange | New York Stock Exchange |
| Sector | Healthcare |
| Industry | Medical Distribution |
| Unique Identifier | NYSE: PBH |
| IPO Date | February 10, 2005 |
Description
Prestige Consumer Healthcare, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare products in North America, Australia, and internationally. It operates in two segments, North American OTC Healthcare and International OTC Healthcare. The company offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids/lozenges, Clear Eyes for eye allergies/redness relief, Compound W wart removals, Debrox ear wax removals, DenTek for PEG oral care, and Dramamine for motion sickness relief. It also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, Fess nasal saline spray, and Hydralyte for oral rehydration products. The company sells through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.